ACR-ABS-ACNM-ASTRO-SIR-SNMMI 肝脏恶性肿瘤选择性内放射治疗或放射性栓塞实践参数
该实践参数由ACR联合ABS、ACNM、ASTRO、SIR、SNMMI共同制定,针对肝脏恶性肿瘤的放射性栓塞治疗,涵盖人员资质、质量保证标准、适应证及文档记录建议,旨在指导临床规范应用。
要点
- 放射性栓塞是向肝脏原发肿瘤或转移瘤的动脉供血行钇-90微球栓塞的近距离治疗。
- 实践参数明确人员资质、质量保证标准和适应证选择等临床实施要求。
- 治疗决策应个体化,权衡临床获益与医疗必要性。
核心结论
- 该实践参数是指导放射性栓塞临床使用的工具,聚焦有效应用时的最佳实践与原则。
研究设计与样本
- 由ACR介入与心血管放射学委员会、核医学与分子影像委员会及放射肿瘤学委员会联合ABS、ACNM、ASTRO、SIR、SNMMI共同修订的实践参数。
临床应用与阅片要点
- 临床实施放射性栓塞需关注人员资质、质量保证标准、适应证及文档记录。
- 治疗应基于每例患者的个体化评估,确保临床获益与医疗必要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The American College of Radiology (ACR), American Brachytherapy Society (ABS), American College of Nuclear Medicine (ACNM), American Society for Radiation Oncology (ASTRO), Society of Interventional Radiology (SIR), and Society of Nuclear Medicine and Molecular Imaging (SNMMI) have jointly developed a practice parameter on selective internal radiation therapy (SIRT) or radioembolization for treatment of liver malignancies. Radioembolization is the embolization of the hepatic arterial supply of hepatic primary tumors or metastases with a microsphere yttrium-90 brachytherapy device.
MATERIALS AND METHODS: The ACR -ABS -ACNM -ASTRO -SIR -SNMMI practice parameter for SIRT or radioembolization for treatment of liver malignancies was revised in accordance with the process described on the ACR website (https://www.acr.org/ClinicalResources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters-Interventional and Cardiovascular Radiology of the ACR Commission on Interventional and Cardiovascular, Committee on Practice Parameters and Technical Standards-Nuclear Medicine and Molecular Imaging of the ACR Commission on Nuclear Medicine and Molecular Imaging and the Committee on Practice Parameters-Radiation Oncology of the ACR Commission on Radiation Oncology in collaboration with ABS, ACNM, ASTRO, SIR, and SNMMI.
RESULTS: This practice parameter is developed to serve as a tool in the appropriate application of radioembolization in the care of patients with conditions where indicated. It addresses clinical implementation of radioembolization including personnel qualifications, quality assurance standards, indications, and suggested documentation.
CONCLUSIONS: This practice parameter is a tool to guide clinical use of radioembolization. It focuses on the best practices and principles to consider when using radioemboliozation effectively. The clinical benefit and medical necessity of the treatment should be tailored to each individual patient.
引用
- Hong K, Akinwande O, Bodei L, et al. ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies. Brachytherapy. 2021. PMID: 33824051. doi:10.1016/j.brachy.2021.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。